DNA & RNA Banking Services Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global DNA & RNA Banking Services Market, By Service Type

7.1.  DNA & RNA Banking Services Market, By Service Type Type, 2020-2030

7.1.1.    Transportation Service

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Processing Service

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Storage Service

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Quality Control Service

7.1.4.1.        Market Revenue and Forecast (2016-2030)

7.1.5.    Data Storage

7.1.5.1.        Market Revenue and Forecast (2016-2030)

7.1.6.    Others

7.1.6.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global DNA & RNA Banking Services Market, By Specimen Type

8.1.  DNA & RNA Banking Services Market, By Specimen Type, 2020-2030

8.1.1.    Blood

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Buccal Swabs & Hair Follicles

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Others

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global DNA & RNA Banking Services Market, By Application Type

9.1.  DNA & RNA Banking Services Market, By Application Type, 2020-2030

9.1.1.    Therapeutics

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Drug Discovery & Clinical Research

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Clinical Diagnostics

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Other Applications

9.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global DNA & RNA Banking Services Market, By End-use Type

10.1.        DNA & RNA Banking Services Market, By End-use Type, 2020-2030

10.1.1.  Academic Research

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Pharmaceutical & Biotechnology Companies

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Hospitals & Diagnostic Centers

10.1.3.1.      Market Revenue and Forecast (2016-2030)

10.1.4.  Others

10.1.4.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global DNA & RNA Banking Services Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, By Service Type (2016-2030)

11.1.2.  Market Revenue and Forecast, By Specimen Type (2016-2030)

11.1.3.  Market Revenue and Forecast, By Application Type (2016-2030)

11.1.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.1.5.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.1.5.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.1.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.1.6.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.1.6.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.1.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, By Service Type (2016-2030)

11.2.2.  Market Revenue and Forecast, By Specimen Type (2016-2030)

11.2.3.  Market Revenue and Forecast, By Application Type (2016-2030)

11.2.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.2.5.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.2.5.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.2.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.2.6.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.2.6.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.2.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.2.7.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.2.7.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.2.7.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.2.8.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.2.8.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.2.8.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, By Service Type (2016-2030)

11.3.2.  Market Revenue and Forecast, By Specimen Type (2016-2030)

11.3.3.  Market Revenue and Forecast, By Application Type (2016-2030)

11.3.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.3.5.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.3.5.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.3.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.3.6.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.3.6.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.3.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.3.7.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.3.7.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.3.7.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.3.8.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.3.8.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.3.8.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, By Service Type (2016-2030)

11.4.2.  Market Revenue and Forecast, By Specimen Type (2016-2030)

11.4.3.  Market Revenue and Forecast, By Application Type (2016-2030)

11.4.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.4.5.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.4.5.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.4.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.4.6.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.4.6.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.4.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.4.7.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.4.7.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.4.7.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.4.8.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.4.8.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.4.8.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, By Service Type (2016-2030)

11.5.2.  Market Revenue and Forecast, By Specimen Type (2016-2030)

11.5.3.  Market Revenue and Forecast, By Application Type (2016-2030)

11.5.4.  Market Revenue and Forecast, By End-use Type (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.5.5.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.5.5.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.5.5.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, By Service Type (2016-2030)

11.5.6.2.      Market Revenue and Forecast, By Specimen Type (2016-2030)

11.5.6.3.      Market Revenue and Forecast, By Application Type (2016-2030)

11.5.6.4.      Market Revenue and Forecast, By End-use Type (2016-2030)

Chapter 12.  Company Profiles

12.1.              EasyDNA

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              DNA Genotek Inc.

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              23andMe, Inc.

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              GoodCell

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              ProteoGenex

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              US Biolab Corporation, Inc.

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Infinity Biologix

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Thermo Fisher Scientific, Inc.

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              deCODE genetics

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Brooks Life Sciences

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           LGC Biosearch Technologies

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           PreventionGenetics

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Report Details

  • Report Code:37244
  • Category:Healthcare
  • No. of Pages:250
  • Format:PDF/PPT/Excel
  • Published:February 2021
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers